Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
Drug manufacturing giant GSK is subverting its pledge to lower the price of its brand-name inhaler products, a key Democratic senator alleged.
In a letter to CEO Emma Walmsley made public Thursday, Sen. Maggie Hassan (D-N.H.) said the company appears to be circumventing its public commitment to cap the price of many of its brand-name inhaler products at $35.
GSK in March was one of three major inhaler manufacturers to commit to capping out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month.
The manufacturer stopped making its Flovent inhaler on Jan. 1 and is instead offering an “authorized generic” version distributed through a different company. It’s the same drug, just without the branding. Flovent was one of the most popular inhalers for young children with asthma.
Yet major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts and OptumRx have largely refused to pay for the generic. If they cover it, the drug is listed on a nonpreferred tier so patients will face higher copays.
GSK has not capped the price of generic fluticasone, and Hassan said the company “appears to be exploiting a licensing agreement with Prasco Laboratories in order to circumvent your public commitments and price-gouge families without access to affordable alternatives to Flovent.”
Hassan is a member of both the Senate Health Committee and the Finance Committee.
Although the list price of the new generic fluticasone inhaler is lower than the previous list price of Flovent HFA, Hassan noted Prasco Laboratories is not offering negotiable pricing terms to insurers to get the product covered on insurance formularies.
This means that families either must pay the full list price — anywhere from $150 to $250 per month — or go without their children’s medication.
The dispute between the drug company and PBMs has left patients with few options.
"Countless children no longer have a single age-appropriate inhaler covered by their insurance plan,” Hassan wrote.
GSK said it received the letter and would respond to the senator.
The company has been under scrutiny in recent months from Sen. Bernie Sanders (I-Vt.) and other Democrats over inhaler pricing.
The company is also facing scrutiny from federal regulators for anticompetitive practices that can delay lower-cost generics from coming to market.
Tens of millions of Americans suffer from asthma and chronic obstructive pulmonary disease (COPD) and rely on inhalers to breathe — about 25 million Americans have asthma, and about 16 million people have COPD.
Date: |
Filter
-
Meghan mania and big skirts: Africa's top shots
A selection of the week's best photos from across the African continent.BBC News - Top stories -
ECB's Schnabel Says Second Rate Cut in July 'Does Not Seem Warranted'
The European Central Bank should move cautiously after delivering a first rate cut in June, a member of its executive board said in an interview.The Wall Street Journal - World -
The story of Labour power, told in pledge cards
Keir Starmer’s 1997-style pitch for votes grasps the party’s strengths and weaknessesFinancial Times - Business -
IDF posting abuse footage despite pledge to act
Images shared online include Palestinian detainees draped in the Israeli flag and held in stress positions.BBC News - Top stories -
Mavs defense stops OKC, Celtics advance + offseason plans for Cavs, Hawks & Lakers | No Cap Room
Jake Fischer and Dan Devine discuss how the Dallas Mavericks won game 5 in Oklahoma City and talk about the offseason rumors swirling at the NBA Draft Combine.Yahoo Sports - Sports - NBA -
China announces sweeping steps to stabilise crisis-hit property sector
Yahoo News - World - China -
EA Sports College Football 25 price: Breaking down cost for each edition as video game returns
EA Sports unveiled plenty of information about its most anticipated release in a long timeCBS Sports - Sports - College Football -
‘Reverse Yankee’ deals boom as Europe’s low borrowing costs lure US groups
American companies issue €30bn in euro-denominated bonds as investor demand for European corporate debt growsFinancial Times - Business
More from The Hill
-
House panels vote to hold Garland in contempt
Two House committees on Thursday advanced measures to hold Attorney General Merrick Garland in contempt of Congress in an effort to censure him for failing to turn over audio recordings of the president. A last-minute move from President Biden to ...The Hill - Politics -
Chaos erupts in hearing as Greene, Ocasio-Cortez clash over ‘fake eyelashes’ jibe at Crockett
A House Oversight Committee hearing devolved into chaos Thursday night as Reps. Marjorie Taylor Greene (R-Ga.) and Alexandria Ocasio-Cortez (D-N.Y.) clashed after the firebrand Republican accused Rep. Jasmine Crockett (D-Texas) of wearing “fake ...The Hill - Politics -
Swalwell slams GOP lawmakers for going to see Trump trial
Rep. Eric Swalwell (D-Calif.) went after his GOP colleagues who traveled to New York City to appear at former President Trump’s criminal trial this week. The California Democrat specifically took it to his colleagues who skipped a hearing Thursday ...The Hill - Politics - Donald Trump -
California bill that would have banned selling anti-aging skin products to young kids fails to advance
A bill in California that sought to ban the sale of anti-aging skin products to young kids failed to advance through the California State Assembly on Thursday. The bill, introduced by Assemblymember Alex Lee, prohibited kids under 13 from buying ...The Hill - Politics - California -
Fox anchor applauds Kansas City Chiefs kicker's controversial remarks
Fox News anchor Laura Ingraham applauded Kansas City Chiefs kicker Harrison Butker on Thursday after he gave controversial speech including remarks on women in the workforce. Butker’s commencement speech at Benedictine College made clear his ...The Hill - Politics - NFL